Paracoccidioidomycosis vaccine

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 10, 2012, Pages 1450-1453

  Travassos, Luiz R ^a   Taborda, Carlos P ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adjuvant; DNA therapy; Gp43; Paracoccidiodes brasiliensis; Peptide P10; Th 1 immune response; Vaccine

Indexed keywords

EID: 84868282656     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.21283     Document Type: Note

References (20)

1. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11:275-88; PMID:21394104; http:// dx.doi.org/10.1038/nri2939.
2. Prado M, Silva MB, Laurenti R, Travassos LR, Taborda CP. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz 2009; 104:513-21; PMID:19547881; http://dx.doi.org/10.1590/S0074- 02762009000300019.
3. Travassos LR, Taborda CP. Paracoccidioidocycosis: Advances in treatment incorporating modulators of the immune response. [Remedica Journals.]. J Invasive Fungal Infect 2011; 5:1-6.
4. Puccia R, Schenkman S, Gorin PA, Travassos LR. Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun 1986; 53:199-206; PMID:2424841.
5. Travassos LR, Goldman G, Taborda CP, Puccia R. Insights in Paracoccidioides brasiliensis pathogenicity. In New Insights in Medical Mycology, Kevin Kavanagh, editor; Springer, Dordrechet, The Netherlands; 2007, pp. 241-265.
6. Taborda CP, Juliano MA, Puccia R, Franco M, Travassos LR. Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect Immun 1998; 66:786-93; PMID:9453642.
7. Iwai LK, Yoshida M, Sidney J, Shikanai-Yasuda MA, Goldberg AC, Juliano MA, et al. In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals. Mol Med 2003; 9:209-19; PMID:15208742.
8. Travassos LR, Taborda CP, Iwai LK, Cunha-Neto E, Puccia R. The gp43 from Paracoccidioides brasiliensis: a major diagnostic antigen and vaccine candidate. In The Mycota XII, Human Fungal Pathogens; JE Domer, GS Kobayashi, editors. Springer-Verlag, Berlin-Heildeberg; 2004, pp. 279-96.
9. Marques AF, da Silva MB, Juliano MA, Travassos LR, Taborda CP. Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis. Antimicrob Agents Chemother 2006; 50:2814- 9; PMID:16870776; http://dx.doi.org/10.1128/ AAC.00220-06.
10. Marques AF, da Silva MB, Juliano MA, Munhõz JE, Travassos LR, Taborda CP. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis. Microbes Infect 2008; 10:1251-8; PMID:18694844; http://dx.doi. org/10.1016/j.micinf.2008.07.027.
11. Taborda CP, Nakaie CR, Cilli EM, Rodrigues EG, Silva LS, Franco MF, et al. Synthesis and immunological activity of a branched peptide carrying the T-cell epitope of gp43, the major exocellular antigen of Paracoccidioides brasiliensis. Scand J Immunol 2004; 59:58-65; PMID:14723622; http://dx.doi. org/10.1111/j.0300-9475.2004.01359.x.
12. Braga CJ, Rittner GM, Muñoz Henao JE, Teixeira AF, Massis LM, Sbrogio-Almeida ME, et al. Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin. Infect Immun 2009; 77:1700-7; PMID:19204092; http://dx.doi. org/10.1128/IAI.01470-08.
13. Mayorga O, Muñoz JE, Lincopan N, Teixeira AF, Ferreira LC, Travassos LR, et al. The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide. Front Microbiol 2012; 3:154; PMID:22586420; http:// dx.doi.org/10.3389/fmicb.2012.00154.
14. Naranjo TW, Lopera DE, Diaz-Granados LR, Duque JJ, Restrepo AM, Cano LE. Combined itraconazolepentoxifylline treatment promptly reduces lung fibrosis induced by chronic pulmonary paracoccidioidomycosis in mice. Pulm Pharmacol Ther 2011; 24:81-91; PMID:20851204; http://dx.doi. org/10.1016/j.pupt.2010.09.005.
15. Amaral AC, Marques AF, Muñoz JE, Bocca AL, Simioni AR, Tedesco AC, et al. Poly(lactic acidglycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis. Br J Pharmacol 2010; 159:1126-32; PMID:20136827; http://dx.doi. org/10.1111/j.1476-5381.2009.00617.x.
16. Magalhães A, Ferreira KS, Almeida SR, Nosanchuk JD, Travassos LR, Taborda CP. Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clin Vaccine Immunol 2012; 19:23-9; PMID:22089247; http:// dx.doi.org/10.1128/CVI.05414-11.
17. Pinto AR, Puccia R, Diniz SN, Franco MF, Travassos LR. DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from paracoccidioides brasiliensis. Vaccine 2000; 18:3050-8; PMID:10825609; http://dx.doi.org/10.1016/S0264- 410X(00)00074-8.
18. Rittner GM, Muñoz JE, Marques AF, Nosanchuk JD, Taborda CP, Travassos LR. Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis. PLoS Negl Trop Dis 2012; 6:e1519; PMID:22389734; http://dx.doi. org/10.1371/journal.pntd.0001519.
19. Travassos LR, Taborda CP. New advances in the development of a vaccine against paracoccidioidomycosis. Front Microbiol 2012; 3:212; PMID:22701452; http://dx.doi.org/10.3389/fmicb.2012.00212.
20. Carvalho A, Cunha C, Iannitti RG, Casagrande A, Bistoni F, Aversa F, et al. Host defense pathways against fungi: the basis for vaccines and immunotherapy. Front Microbiol 2012; 3:176; PMID:22590466; http://dx.doi.org/10. 3389/fmicb.2012.00176.